ClinicalTrials.Veeva

Menu

Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in CVD

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Cardiovascular Diseases

Treatments

Behavioral: Lifestyle Management
Behavioral: Control Group

Study type

Interventional

Funder types

Other

Identifiers

NCT03643146
17-01791

Details and patient eligibility

About

The objective of the proposed project is to evaluate the usability, acceptability, and adherence of a lifestyle and behavioral self-tracking and ePersuasive tool aimed at improving: 1) adherence to diet/nutrition (<1500 mg of sodium/day and less than 10% daily free sugar intake), physical activity (PA) (150 minutes of moderate PA/week), and sleep guidelines (7-8 hours of sleep/day)-- and 2) control 3% reduction in systolic BP and glucose from baseline to end of study follow-up after 2 months (exploratory objective) in a sample of 20 patients with Hypertension or Diabetes. The study will utilize a Step-Wedge Design where the 20 patients will be divided into 4 wedges (5 patients in each wedge).

Enrollment

23 patients

Sex

All

Ages

18 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • NYU and/or Bellevue patient
  • Diagnosed with HTN and pre-diabetes/diabetes
  • Must be English speakers
  • Ownership of a smart phone and are willing to use it to download app built in TrialX which will be free for participants
  • Must be ambulatory

Exclusion criteria

  • are unable or unwilling to provide informed consent;
  • are unable to participate meaningfully in an intervention that involves self-monitoring using software available in English (e.g., due to uncorrected sight impairment, illiterate, non-English-speaking, dementia);
  • are pregnant, are currently trying to become pregnant, or who become pregnant during the study
  • are institutionalized (e.g., in a nursing home or personal care facility, or those who are incarcerated and have limited control over self-management)
  • have had or are planning to have bariatric surgery during the study
  • have a history of heart disease, kidney disease, or retinopathy (to rule-out those with long-standing, undiagnosed T2D)

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

23 participants in 20 patient groups

Wedge 1- Step 1
Experimental group
Treatment:
Behavioral: Control Group
Wedge 1-Step 2
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 1-Step 3
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 1-Step 4
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 1-Step 5
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 2- Step 1
Experimental group
Treatment:
Behavioral: Control Group
Wedge 2-Step 2
Experimental group
Treatment:
Behavioral: Control Group
Wedge 2-Step 3
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 2-Step 4
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 2-Step 5
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 3-Step 1
Experimental group
Treatment:
Behavioral: Control Group
Wedge 3- Step 2
Experimental group
Treatment:
Behavioral: Control Group
Wedge 3- Step 3
Experimental group
Treatment:
Behavioral: Control Group
Wedge 3- Step 4
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 3- Step 5
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 4-Step 1
Experimental group
Treatment:
Behavioral: Control Group
Wedge 4- Step 2
Experimental group
Treatment:
Behavioral: Control Group
Wedge 4-Step 3
Experimental group
Treatment:
Behavioral: Control Group
Wedge 4-Step 4
Experimental group
Treatment:
Behavioral: Lifestyle Management
Wedge 4-Step 5
Experimental group
Treatment:
Behavioral: Lifestyle Management

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems